FBXL5 and cervical cancer: The acquisition of EMT features represents a key contributor to chemoresistance in cervical cancer, thus the expression of the EMT repressors F-Box and Leucine Rich Repeat Protein 5 (FBXL5) and BTG Anti-Proliferation Factor 3 (BTG3) is retained low in cancer tissues and cisplatin-resistant cells.